Table V.
Supportive care recommendations in human monkeypox
| Wound care | Pain control | Scarring |
|---|---|---|
| Maintain clean and moist environment | Multimodal non-opioid analgesia: first line | Prevention |
| Cleanse wound with gentle soap and water daily | Systemic: acetaminophen, NSAIDs (oral, IV; if tolerated) | Optimize wound care and healing |
| Apply gelling fiber, foam, or ointment (Vaseline, MediHoney) to clean wound before replacing a fixed dressing (eg, Tegaderm, loose gauze dressing secured by medical tape) daily | Topical: lidocaine preparations, cool packs | Avoid secondary skin infection |
| Avoid secondary skin infection | Severe, refractory pain | Facilitate resolution of dyspigmentation |
| Advise patient to avoid manipulating lesions/scabs | Consider hospitalization, opioids, and/or palliative care or pain consultation | Sun protection (avoidance, sunscreen) and fading agents (retinoids, hydroquinone) |
| Treat secondary skin infections | Pain at mucosal sites and mucosal edema | Cosmetics referral |
| Topical and/or systemic antibiotics only if clinical evidence of infection | Rectal: lidocaine or other topical numbing agent, hydrocortisone 1%, pramoxine | Laser, peels |
| Incision and drainage if evidence of abscess | Oropharyngeal: magic mouthwash, lidocaine gel, liquid morphine | |
| Note: Consider consultants for wounds in special sites (eye, anal, or genital lesions) | Note: Monitor for ability to maintain oral intake, IV hydration as needed | Note: Screen for psychological sequelae from scarring and refer to mental health services as appropriate |
IV, Intravenous; NSAIDs, non-steroidal anti-inflammatory drugs.